Tags:BioTech
Aptinyx is a biotechnology company developing innovative therapies for neurological disorders.
Total raised: $70M

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
18.12.2017Series B$70M-Aptinyx Ra...

Mentions in press and media 12

DateTitleDescriptionCategoryAuthorSource
29.11.20185 startup ...2018 is quickly drawing to its...-Pete Wilki...venturebea...
03.10.2018Chicago’...Today, PitchBook revealed its ...-Pete Wilki...venturebea...
24.05.2018Aptinyx lo...A day af­ter Aptinyx closed a...FinancingJohn Carro...endpts.com...
28.12.2017Midwest Re...While we’re primarily focuse...Stories F...-bizjournal...
28.12.2017Midwest Re...While we’re primarily focuse...Stories F...-bizjournal...
26.12.2017Chicago Te...Chicago-area tech and startup ...Stories F...-bizjournal...
18.12.2017Term Sheet...UBER DRAMA Good morning, Term...--fortune.co...
18.12.2017Bain Capit...Aptinyx Inc., a clinical-stage...--citybizlis...
18.12.2017Biopharma ...Local biopharmaceutical startu...Stories F...-bizjournal...
18.12.2017Aptinyx Ra...Aptinyx, Inc., an Evanston, IL...USA-finsmes.co...
Show more